Physician profile
Kathleen E Shimp
NPI 1134128259
$2,101.24
in general payments reported to CMS, 2019-2025
34 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $191 · 2021: $459 · 2022: $277 · 2023: $275 · 2024: $237 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $234.08 | 2019-2025 | Aptima |
| Mayne Pharma Commercial LLC | $220.71 | 2022-2025 | |
| Pfizer INC. | $212.05 | 2019-2024 | |
| Abbvie INC. | $184.48 | 2019-2022 | |
| Astellas Pharma US INC | $178.69 | 2019-2025 | Veozah |
| Exeltis, USA INC. | $161.77 | 2020-2024 | Slynd |
| Exact Sciences Corporation | $101.64 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $96.03 | 2021-2024 | Wallach Cryosurgical Equipment, Summit Doppler, Paragard T 380a |
| Myovant Sciences INC. | $73.98 | 2021-2022 | |
| Organon LLC | $53.65 | 2021-2023 | Nexplanon |
| Duchesnay USA Incorporated | $52.37 | 2019 | |
| Amgen INC. | $44.11 | 2019-2021 | |
| Daiichi Sankyo INC. | $41.30 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $40.57 | 2025 | Myfembree |
| Merck Sharp & Dohme LLC | $37.66 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $31.32 | 2019 | |
| Lupin INC. | $30.13 | 2019-2020 | |
| Channel Medsystems, INC. | $29.70 | 2023 | |
| Biocryst US Sales Co., LLC | $27.52 | 2022 | |
| Baxter Healthcare | $24.38 | 2021 | |
| Avion Pharmaceuticals | $23.67 | 2020-2022 | |
| Medicem INC. | $22.71 | 2020-2021 | |
| Inari Medical, INC. | $21.22 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $19.28 | 2019 | |
| Axonics, INC. | $18.37 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.80 | 2021 | |
| Millicent US INC | $16.40 | 2020 | |
| Avanos Medical | $16.38 | 2019 | |
| Evofem Biosciences, INC. | $14.23 | 2021 | |
| Agile Therapeutics, INC. | $14.17 | 2021 | |
| Caldera Medical, INC | $14.15 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $13.84 | 2021 | |
| Therapeuticsmd, INC. | $12.88 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Shimp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.